Skip to main content
Glama

Compare Entities

compare_entities
Read-onlyIdempotent

"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valuesYesFor company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]).

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. First observed

TDQS

A4.9/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

The description adds significant context beyond annotations, detailing data sources (EDGAR/XBRL for companies, FAERS for drugs), handling of fiscal year offsets, sorting by primary metric, and citation URIs. No contradictions.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is informative and well-structured, but slightly verbose with example phrases. Each sentence adds value, though minor trimming could improve conciseness.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Given the tool's complexity (two entity types, multiple data sources) and no output schema, the description covers purpose, triggers, usage preference, entity specifics, data details, sorting, and return format. Complete for agent decision-making.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, but the description adds meaning by explaining valid parameter values (tickers/CIKs for company, names for drug), constraints (2-5 items), and data retrieval behavior for each type.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description explicitly states the tool's purpose: side-by-side comparison of 2-5 companies or drugs in one parallel call. It provides clear trigger phrases and distinguishes from sequential single-pack lookups.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description explicitly advises 'ALWAYS PREFER over sequential single-pack lookups when comparing entities.' It also provides natural language examples to guide when to use the tool.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.6/5.0
Disambiguation2/5

Several tools have heavily overlapping purposes: ask_pipeworx and ask_pipeworx_beta are described as currently identical, and the polymarket_* family (edges, arbitrage, edge_tracker, fill_risk, kalshi_spread) all target prediction-market analysis with fuzzy boundaries. ai_visibility_check and scan_competitor_ai_presence overlap as well. While some tools are clearly distinct (art search vs memory), the set as a whole requires careful reading to avoid misselection.

Naming Consistency2/5

Tool names follow multiple patterns: verb_noun (search_artworks, resolve_entity, validate_claim), domain_prefixed (polymarket_*, pipeworx_*), and product-style names (ask_pipeworx, bet_research, deep_research). Versioned suffixes like ask_pipeworx_beta and ask_pipeworx_grounded break any unified convention. Even though subgroups are internally consistent, the overall pattern is mixed and unpredictable.

Tool Count2/5

34 tools is on the high side, especially for a server named after an art museum. Only 3 tools actually relate to the Minneapolis Institute of Art, while the rest are a general-purpose data platform, prediction-market analysis, and memory/subscription features. Many of these extra tools are redundant or power-user variations, making the count feel inflated relative to the apparent domain.

Completeness3/5

For the stated art domain, the read-only surface (search, get, department highlights) is functional but thin — no artist browse, exhibitions, or advanced filtering. The broader data tools are comprehensive in themselves, but their presence distracts from the core domain and creates confusion about the server's intended purpose. The art coverage is adequate for basic queries but lacks depth expected from a dedicated museum collection API.